AAAAAA

   
Results: 1-13 |
Results: 13

Authors: BALZARINI J PELEMANS H ESNOUF R DECLERCQ E
Citation: J. Balzarini et al., A NOVEL MUTATION (F227L) ARISES IN THE REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ON DOSE-ESCALATING TREATMENT OF HIV TYPE 1-INFECTED CELL-CULTURES WITH THE NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR THIOCARBOXANILIDE UC-781, AIDS research and human retroviruses, 14(3), 1998, pp. 255-260

Authors: PELEMANS H ESNOUF RM PARNIAK MA VANDAMME AM DECLERCQ E BALZARINI J
Citation: H. Pelemans et al., A PROLINE-TO-HISTIDINE SUBSTITUTION AT POSITION-225 OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) REVERSE-TRANSCRIPTASE (RT) SENSITIZES HIV-1 RT TO BHAP U-90152, Journal of General Virology, 79, 1998, pp. 1347-1352

Authors: BALZARINI J PELEMANS H RIESS G ROESNER M WINKLER I DECLERCQ E KLEIM JP
Citation: J. Balzarini et al., RETENTION OF MARKED SENSITIVITY TO HYLTHIOMETHYL)-3,4-DIHYDROQUINOXALINE-2(1H)-THIONE (HBY-097) BY AN AZIDOTHYMIDINE (AZT)-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) STRAIN SUBCULTURED IN THE COMBINED PRESENCE OF QUINOXALINE HBY-097 AND 2',3'-DIDEOXY-3'-THIACYTIDINE (LAMIVUDINE), Biochemical pharmacology, 55(5), 1998, pp. 617-625

Authors: BALZARINI J PELEMANS H DECLERCQ E KARLSSON A KLEIM JP
Citation: J. Balzarini et al., REVERSE-TRANSCRIPTASE FIDELITY AND HIV-1 VARIATION, Science, 275(5297), 1997, pp. 229-230

Authors: PELEMANS H ESNOUF R DUNKLER A PARNIAK MA VANDAMME AM KARLSSON A DECLERCQ E KLEIM JP BALZARINI J
Citation: H. Pelemans et al., CHARACTERISTICS OF THE PRO225HIS MUTATION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) REVERSE-TRANSCRIPTASE THAT APPEARS UNDER SELECTIVEPRESSURE OF DOSE-ESCALATING QUINOXALINE TREATMENT OF HIV-1, Journal of virology, 71(11), 1997, pp. 8195-8203

Authors: BALZARINI J PELEMANS H RIESS G ROESNER M WINKLER I DECLERCQ E KLEIM JP
Citation: J. Balzarini et al., ZIDOVUDINE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STRAINS SUBCULTURED IN THE PRESENCE OF BOTH LAMIVUDINE AND QUINOXALINE HBY-097 RETAIN MARKED SENSITIVITY TO HBY-097 BUT NOT TO LAMIVUDINE, The Journal of infectious diseases, 176(5), 1997, pp. 1392-1397

Authors: BALZARINI J PELEMANS H KARLSSON A DECLERCQ E KLEIM JP
Citation: J. Balzarini et al., CONCOMITANT COMBINATION THERAPY FOR HIV-INFECTION PREFERABLE OVER SEQUENTIAL THERAPY WITH 3TC AND NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS, Proceedings of the National Academy of Sciences of the United Statesof America, 93(23), 1996, pp. 13152-13157

Authors: BALZARINI J PELEMANS H AQUARO S PERNO CF WITVROUW M SCHOLS D DECLERCQ E KARLSSON A
Citation: J. Balzarini et al., HIGHLY FAVORABLE ANTIVIRAL ACTIVITY AND RESISTANCE PROFILE OF THE NOVEL THIOCARBOXANILIDE PENTENYLOXY ETHER DERIVATIVES UC-781 AND UC-82 ASINHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION, Molecular pharmacology, 50(2), 1996, pp. 394-401

Authors: BALZARINI J PELEMANS H PEREZPEREZ MJ SANFELIX A CAMARASA MJ DECLERCQ E KARLSSON A
Citation: J. Balzarini et al., MARKED INHIBITORY ACTIVITY OF NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WHEN COMBINED WITH(-)2',3'-DIDEOXY-3'-THIACYTIDINE, Molecular pharmacology, 49(5), 1996, pp. 882-890

Authors: BALZARINI J WEDGWOOD O KRUINING J PELEMANS H HEIJTINK R DECLERCQ E MCGUIGAN C
Citation: J. Balzarini et al., ANTI-HIV AND ANTI-HBV ACTIVITY AND RESISTANCE PROFILE OF 2',3'-DIDEOXY-3'-THIACYTIDINE (3TC) AND ITS ARYLPHOSPHORAMIDATE DERIVATIVE CF-1109, Biochemical and biophysical research communications, 225(2), 1996, pp. 363-369

Authors: BALZARINI J PELEMANS H DECLERCQ E CAMARASA MJ KARLSSON A
Citation: J. Balzarini et al., COMBINATION OF 3TC WITH NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS GREATLY INCREASES THE ACTIVITY OF THE INHIBITORS AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN CELL-CULTURE, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 16-16

Authors: MICHIELS J PELEMANS H VLASSAK K VERRETH C VANDERLEYDEN J
Citation: J. Michiels et al., IDENTIFICATION AND CHARACTERIZATION OF A RHIZOBIUM-LEGUMINOSARUM BV PHASEOLI GENE THAT IS IMPORTANT FOR NODULATION COMPETITIVENESS AND SHOWS STRUCTURAL HOMOLOGY TO A RHIZOBIUM-FREDII HOST-INDUCIBLE GENE, Molecular plant-microbe interactions, 8(3), 1995, pp. 468-472

Authors: MICHIELS J DHOOGHE I VERRETH C PELEMANS H VANDERLEYDEN J
Citation: J. Michiels et al., CHARACTERIZATION OF THE RHIZOBIUM-LEGUMINOSARUM BIOVAR PHASEOLI NIFA GENE, A POSITIVE REGULATOR OF NIF GENE-EXPRESSION, Archives of microbiology, 161(5), 1994, pp. 404-408
Risultati: 1-13 |